Guizhou Xinbang Pharmaceutical Co., Ltd. announced earnings results for the half year ended June 30, 2019. For the half year, the company announced sales was CNY 3,277.630 million compared to CNY 3,273.849 million a year ago. Operating income was CNY 154.837 million compared to CNY 231.049 million a year ago. Net income was CNY 121.320 million compared to CNY 195.638 million a year ago. Basic earnings per share from continuing operations was CNY 0.07 compared to CNY 0.12 a year ago.